Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Indolent lymphomas; advances from ASH 2012
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Indolent lymphomas; advances from ASH 2012 ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
18 Dec 2012
Overview of multiple myeloma with Maria Victoria Mateos
Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
Overview of multiple myeloma with Maria Victoria Mateos ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
18 Dec 2012
Advances and updates in treatments for myeloma presented at ASH 2012
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Advances and updates in treatments for myeloma presented at ASH 2012 ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
18 Dec 2012
Advances in myeloma at ASH 2012 (2/2)
Prof Gareth Morgan - The Royal Marsden Hospital, London
Advances in myeloma at ASH 2012 (2/2) ( Prof Gareth Morgan - The Royal Marsden Hospital, London )
18 Dec 2012
Advances in myeloma at ASH 2012 (1/2)
Prof Gareth Morgan - The Royal Marsden Hospital, London
Advances in myeloma at ASH 2012 (1/2) ( Prof Gareth Morgan - The Royal Marsden Hospital, London )
18 Dec 2012
Pre-Implantation genetic diagnosis
Dr Alison Lashwood - Guy's Hospital, London, UK
Pre-Implantation genetic diagnosis ( Dr Alison Lashwood - Guy's Hospital, London, UK )
17 Dec 2012
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer...
Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study ( Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
17 Dec 2012
MLN9708 in combination with lenalidomide and dexamethasone against multiple...
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
17 Dec 2012
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid...
Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML) ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
17 Dec 2012
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients
Professor Meletios Dimopoulos - University of Athens, Greece
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients ( Professor Meletios Dimopoulos - University of Athens, Greece )
16 Dec 2012
MLN9708 in combination with lenalidomide and dexamethasone
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
16 Dec 2012
History of epidermal stem cell use in the clinical setting
Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy
History of epidermal stem cell use in the clinical setting ( Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy )
14 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation